How challenging it is to recruit patients and do clinical trials in France compared to other places?
This is a major challenge and we have clearly seen a lot of activities moving to Eastern Europe, as well as outside of Europe to the East and South. Thus we have to be smarter and more efficient to make sure that France can provide high-quality patients in order to proceed with clinical trials. It is imperative that we develop an intimate relationship with investigators’ sites. In this model Quintiles acts as an ally with its partner sites – providing support in terms of training, IT and in some instances site personnel. In terms this allows the site to focus on the patient and recruiting the right subjects into the right studies at the right time. This is the smart way to respond to the globalization of clinical research. We have also developed a very close relationship with the regulatory authorities so we can truly understand what they are trying to achieve. In order to improve the system and work together bridging the industry and the public good, we have close contact with senior
